Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Upcoming E-conference

No Record Found!!

Startup

Bayer awards incubator opportunity to Genvor
Bayer awards incubator opportunity to Genvor
HealthCRED secures US$ 1.2 million in seed funding
HealthCRED secures US$ 1.2 million in seed funding
IIHMR Start-ups inks MoU with BMCHRC & HCG Hospital
IIHMR Start-ups inks MoU with BMCHRC & HCG Hospital
View More

Digitization

National conference on `Universal Access to Health care: Digital Solutions’ at IHC
National conference on `Universal Access to Health care: Digital Solutions’ at IHC
Experts discuss on AI-driven solutions to improve healthcare
Experts discuss on AI-driven solutions to improve healthcare
Mastek and Onyx Health partner to accelerate healthcare data interoperability
Mastek and Onyx Health partner to accelerate healthcare data interoperability
View More

Latest Stories

USFDA determines inspection classification of VAI for the contract manufacturing facility at Spokane, Washington

Zydus Lifesciences announces completion of Phase II(a) clinical trial of Usnoflast

Health Ministry releases "Health Dynamics of India (Infrastructure and Human Resources) 2022-23"

Atal Innovation Mission, NITI Aayog hosts 20th MedTech Mitra Technical advisory meeting

Presence of Mpox virus of West African clade 2 confirmed in isolated patient

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion
Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA
Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA
Urgent need to redefine pharma companies’ role on several issues of the industry: Dr. K. Nagaiah, Chief Scientist, CSIR - IICT, Hyderabad
Urgent need to redefine pharma companies’ role on several issues of the industry: Dr. K. Nagaiah, Chief Scientist, CSIR - IICT, Hyderabad

Interviews
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
Vinod Paremal President & MD, Evonik, India Region

Packaging